Association of serum sclerostin levels with low skeletal muscle mass: The Korean Sarcopenic Obesity Study (KSOS)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jung A. | - |
dc.contributor.author | Roh, Eun | - |
dc.contributor.author | Hong, So-hyeon | - |
dc.contributor.author | Lee, You-Bin | - |
dc.contributor.author | Kim, Nam Hoon | - |
dc.contributor.author | Yoo, Hye Jin | - |
dc.contributor.author | Seo, Ji A. | - |
dc.contributor.author | Kim, Nan Hee | - |
dc.contributor.author | Kim, Sin Gon | - |
dc.contributor.author | Baik, Sei Hyun | - |
dc.contributor.author | Choi, Kyung Mook | - |
dc.date.accessioned | 2021-09-01T01:27:04Z | - |
dc.date.available | 2021-09-01T01:27:04Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 8756-3282 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62097 | - |
dc.description.abstract | Background Sclerostin is an osteocyte-derived circulating protein that inhibits the Wnt/beta-catenin signaling pathway. The Wnt signaling pathway plays an important role in bone and dysregulation of the Wnt signaling pathway results in insulin resistance, inflammation, and metabolic disturbance. The aim of our study was to investigate the implication of sclerostin in low muscle mass in healthy subjects. Methods: The cross-sectional study analyzed 240 healthy non-diabetic subjects from the Korean Sarcopenic Obesity Study (KSOS). Low muscle mass was defined as the sum of the appendicular skeletal muscle mass divided by the square of height (ASM/height(2)) as proposed by the Asian Working Group for Sarcopenia. Results: Serum sclerostin was significantly higher in the low muscle mass group than the normal muscle mass group (151.3 [79.2-187.9] vs. 74.8 [47.6-119.6] pg/mL, p = 0.001). In the partial correlation analyses adjusted for age, sex, and body mass index, ASM/height(2) was negatively associated with sclerostin levels (r = - 0.245, p < 0.001). Furthermore, sclerostin levels decreased linearly according to the first, second, and third tertiles of ASM/height(2) even after adjusting for sex, age, body mass index, life style parameters, fasting plasma glucose, bone mineral content (BMC), and total body fat mass. Conclusions: Serum sclerostin levels were negatively correlated to skeletal muscle mass independent of confounding factors including BMC and total body fat mass. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject | BONE-MINERAL DENSITY | - |
dc.subject | INSULIN-RESISTANCE | - |
dc.subject | WORKING GROUP | - |
dc.subject | PATHWAY | - |
dc.subject | FAT | - |
dc.subject | OSTEOPOROSIS | - |
dc.subject | DISEASE | - |
dc.title | Association of serum sclerostin levels with low skeletal muscle mass: The Korean Sarcopenic Obesity Study (KSOS) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Nam Hoon | - |
dc.contributor.affiliatedAuthor | Yoo, Hye Jin | - |
dc.contributor.affiliatedAuthor | Seo, Ji A. | - |
dc.contributor.affiliatedAuthor | Kim, Nan Hee | - |
dc.contributor.affiliatedAuthor | Kim, Sin Gon | - |
dc.contributor.affiliatedAuthor | Baik, Sei Hyun | - |
dc.contributor.affiliatedAuthor | Choi, Kyung Mook | - |
dc.identifier.doi | 10.1016/j.bone.2019.115053 | - |
dc.identifier.scopusid | 2-s2.0-85071532579 | - |
dc.identifier.wosid | 000493584700018 | - |
dc.identifier.bibliographicCitation | BONE, v.128 | - |
dc.relation.isPartOf | BONE | - |
dc.citation.title | BONE | - |
dc.citation.volume | 128 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | BONE-MINERAL DENSITY | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | WORKING GROUP | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | FAT | - |
dc.subject.keywordPlus | OSTEOPOROSIS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordAuthor | Sclerostin | - |
dc.subject.keywordAuthor | Wnt pathway | - |
dc.subject.keywordAuthor | Low skeletal muscle mass | - |
dc.subject.keywordAuthor | Bone muscle interaction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.